Knee muscle function recovery of patients with knee osteoarthritis: Treatment and evaluation

doi:10.3969/j.issn.2095-4344.2013.46.024

Abstract

Abstract:

BACKGROUND: Muscle atrophy and weakness exist around the knee joint of patients with knee osteoarthritis, comprehensive treatment combined with training muscle power around knee joint can obviously relieve symptoms and restore muscle power around the knee joint.
OBJECTIVE: To test the relationship between muscle function around the knee joint and the knee joint function with isokinetic muscle strength test before and after comprehensive treatment of knee osteoarthritis, and to investigate the pathological mechanisms of knee osteoarthritis in order to provide basis for the clinical rehabilitation and treatment.
METHODS: We screened out 30 subjects with unilateral knee osteoarthritis (stage Ⅱ and Ⅲ). Hospital for Special Surgery was used to evaluate the knee function, and visual analogue scale score was used to assess the patient pain. The knee muscle function of knee osteoarthritis patients was measured before treatment; the patients with knee osteoarthritis at stage Ⅱ and Ⅲ received comprehensive treatment for at least 1 month (active quadriceps isometric muscle strengthening exercises, oral celecoxib capsules combined with intra-articular injection of sodium hyaluronate), and knee muscle function was measured after treatment. Hospital for Special Surgery and the visual analogue scale score were evaluated during follow-up period.
RESULTS AND CONCLUSION: Compared with the healthy side, the muscle power of the affected side of the patients with knee osteoarthritis was decreased when the flexion and extension muscle peak torque and work volume tested at 60 (°)/s and 180 (°)/s (P < 0.05). After comprehensive treatment, the Hospital for Special Surgery scores of the knee osteoarthritis patients were increased significantly (P < 0.05), while the visual analogue scale scores were decreased (P < 0.05), and the muscle power of the affected side was increased significantly (P < 0.05); there was no significant difference in the muscle power between affected side and healthy side after treatment (P > 0.05). There was no significant difference in the peak torque ratio of quadriceps and hamstring measured at 60 (°)/s in the knee osteoarthritis patients before and after treatment (P > 0.05), and there was significant difference measured at 180 (°)/s (P < 0.05). Knee osteoarthritis patients have decreased muscle strength around the knee joint, and the comprehensive treatment of muscle functional training combined with effective pain relief and nutrition joint drugs can significantly relieve symptoms, improve muscle strength and restore knee function

Key words: osteoarthritis, knee, osteoarthritis, arthritis, arthralgia, pain

CLC Number:

R318

Li Yi,Yao Jian-feng, Wu Liang, Liang Xiao-jun, Chen Peng, Ma Yan. Knee muscle function recovery of patients with knee osteoarthritis: Treatment and evaluation[J]. Chinese Journal of Tissue Engineering Research, 2013, 17(46): 8128-8132.

Figures/Tables 3

References

[1]Rousseau JC, Delmas PD. Biological markers in osteoarthritis. Nat Clin Pract Rheumatol. 2007;3(6):346-356.
[2]Cheung PP, Gossec L, Dougados M. What are the best markers for disease progression in osteoarthritis (OA)? Best Pract Res Clin Rheumatol. 2010;24(1):81-92.
[3]Slemenda C, Brandt KD, Heilman DK, et al. Quadriceps weakness and osteoarthritis of the knee. Ann Intern Med. 1997; 127(2):97-104.
[4]Bennell KL, Wrigley TV, Hunt MA, et al. Update on the role of muscle in the genesis and management of knee osteoarthritis. Rheum Dis Clin North Am. 2013;39(1):145-176.
[5]Bennell KL, Hunt MA, Wrigley TV, et al. Muscle and exercise in the prevention and management of knee osteoarthritis: an internal medicine specialist's guide. Med Clin North Am. 2009; 93(1):161-177, xii.
[6]Kon E, Filardo G, Drobnic M, et al. Non-surgical management of early knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2012;20(3):436-449.
[7]Diehl P, Gerdesmeyer L, Schauwecker J, et al. [Conservative therapy of osteoarthritis]. Orthopade. 2013;42(2):125-139.
[8]Insall JN, Ranawat CS, Aglietti P, et al. A comparison of four models of total knee-replacement prostheses. J Bone Joint Surg Am. 1976;58(6):754-765.
[9]Hofmann AA, Bloebaum RD, Koller KE, et al. Does celecoxib have an adverse effect on bone remodeling and ingrowth in humans? Clin Orthop Relat Res. 2006;452:200-204.
[10]Schroer WC, Diesfeld PJ, LeMarr AR, et al. Benefits of prolonged postoperative cyclooxygenase-2 inhibitor administration on total knee arthroplasty recovery: a double-blind, placebo-controlled study. J Arthroplasty. 2011; 26(6 Suppl):2-7.
[11]Hegazy R, Alashhab M, Amin M. Cardiorenal effects of newer NSAIDs (Celecoxib) versus classic NSAIDs (Ibuprofen) in patients with arthritis. J Toxicol. 2011;2011:862153.
[12]Lee W, Suh JW, Yang HM, et al. Celecoxib does not attenuate the antiplatelet effects of aspirin and clopidogrel in healthy volunteers. Korean Circ J. 2010;40(7):321-327.
[13]Strand V, Simon LS, Dougados M, et al. Treatment of osteoarthritis with continuous versus intermittent celecoxib. J Rheumatol. 2011;38(12):2625-2634.
[14]Chan FK, Lanas A, Scheiman J, et al. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet. 2010;376(9736):173-179.
[15]Lanas A, Tornero J, Zamorano JL. Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study. Ann Rheum Dis. 2010;69(8):1453-1458.
[16]Cryer B, Li C, Simon LS, et al. GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded endpoint (PROBE) trial. Am J Gastroenterol. 2013;108(3):392-400.
[17]Peri? A, Toski?-Radoji?i? M, Dobri? S, et al. Are COX-2 inhibitors preferable to combined NSAID and PPI in countries with moderate health service expenditures? J Eval Clin Pract. 2010;16(6):1090-1095.
[18]Kon E, Mandelbaum B, Buda R, et al. Platelet-rich plasma intra- articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy. 2011;27(11):1490-1501.
[19]Filardo G, Kon E, Pereira Ruiz MT, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2012;20(10):2082-2091.
[20]Jüni P, Rutjes AW, da Costa BR, et al. Viscosupplementation for osteoarthritis of the knee. Ann Intern Med. 2013;158(1):75.
[21]Swi?chowicz S, Osta?owska A, Kasperczyk A, et al. Evaluation of hyaluronic acid intra-articular injections in the treatment of primary and secondary osteoarthritis of the knee. Pol Orthop Traumatol. 2012;77:105-109.
[22]McArthur BA, Dy CJ, Fabricant PD, et al. Long term safety, efficacy, and patient acceptability of hyaluronic acid injection in patients with painful osteoarthritis of the knee. Patient Prefer Adherence. 2012;6:905-910.
[23]Navarro-Sarabia F, Coronel P, Collantes E, et al. A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis. 2011;70(11):1957-1962.
[24]Chevalier X. Forty-month trial suggests repeated hyaluronic acid injections for people with knee osteoarthritis may act as a long- term slow acting drug. Evid Based Med. 2012;17(6):188-189.
[25]Atkins DV, Eichler DA. The effects of self-massage on osteoarthritis of the knee: a randomized, controlled trial. Int J Ther Massage Bodywork. 2013;6(1):4-14.
[26]蒋奇永，徐秀林.等长肌力测试的研究与应用[J].中国组织工程研究与临床康复,2011,15(15):2813-2816.
[27]Rosa UH, Velásquez Tlapanco J, Lara Maya C, et al. Comparison of the effectiveness of isokinetic vs isometric therapeutic exercise in patients with osteoarthritis of knee. Reumatol Clin. 2012;8(1):10-14.